Schott M, Schatz D, Atkinson M, Krischer J, Mehta H, Vold B und Maclaren N: GAD65Autoantibodies Increase the Predictibility but not the Sensitivity of Islet Cell and Insulin Autoantibodies for Developing Insulin Dependent Diabetes Mellitus. J Autoimmun 1994, 7:865-872 (IF: 7.231, PCI:31)
Seissler J, Schott M, Steinbrenner H, Peterson P, Krohn KJE und Scherbaum WA: Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison’s disease and autoimmune polyglandular syndrome type II. Exp Clin Endocr Diab 1999, 107:208-13 (IF: 1.685, PCI:18)
Seissler J, Schott M, Boms S, Wohlrab U, Ostendorf B, Morgenthaler NG und Scherbaum WA: Autoantibodies to tissue transglutaminase identify silent coeliac diesase in type 1 diabetes. Diabetologia 1999; 42:1440-41 (IF: 6.551, PCI:22)
Schott M, Seissler J, Feldkamp J, von Schilling C und Scherbaum WA: Dendritic cell immunotherapy induces antitumor response in parathyroid carcinoma and neuroendocrine pancreas carcinoma. Horm Metab Res 1999, 31:662-664 (IF: 2.686, PCI:8)
Schott M, Feldkamp J, Bathan C, Fritzen R, Scherbaum WA und Seissler J: Detecting TSH-receptor antibodies with the recombinant TBII assay: Technical and clinical evaluation. Horm Metab Res 2000, 32:429-435 (IF: 2.686, PCI:48)
Schattenberg D, Schott M, Reindl G, Krueger T, Tschoepe D, Feldkamp J, Scherbaum WA und Seissler J: Response of human monocyte-derived dendritic cells to immunostimulatory DNA. Eur J Immunol 2000, 30 (10):2824-31 (IF: 5.179, PCI:24)
Seissler J, Schott M, Morgenthaler NG und Scherbaum WA: Mapping of novel autoreactive epitopes of the diabetes-associated autoantigen IA-2. Clin Exp Immunol 2000, 122:157-63 (IF: 3.009, PCI:13)
Seissler J, Wagner S, Schott M, Lettmann M, Feldkamp J, Scherbaum WA und Morgenthaler NG: Low frequency of autoantibodies to the human Na+/J-symporter (NIS) in patients with autoimmune thyroid disease. J Clin Endocr Metab 2000, 85 (12):4630-4 (IF: 6.202, PCI:15)
Feldkamp J, Pascher E, Schott M, Seissler J, und Scherbaum WA: Soluble Fas is increased in hyperthyroidism independent of the underlying thyroid disease. J Clin Endocr Metab 2001, 86(9):4520-4253 (IF: 6.202, PCI:11)
Schott M, Seissler J, Lettmann M, Fouxon V, Scherbaum WA und Feldkamp J: Immunotherapy for medullary thyroid carcinoma by dendritic cell vaccination. J Clin Endocinol Metab 2001, 86:4965-9 (IF: 6.202, PCI:47)
Seissler J, Eikamp K, Schott M und Scherbaum WA: IA-2 Autoantibodies restricted to the IgG4 Subclass are Associated with Protection from Type 1 Diabetes. Horm Metab Res 2002, 34(4):186-191 (IF: 2.686, PCI:11)
Schott, M, Feldkamp, J, Klucken, M, Kobbe, G, Scherbaum, WA. und Seissler J: Calcitonin-specific antitumor immunity in medullary thyroid carcinoma following dendritic cell vaccination. Cancer Immunol Immun 2002, 51:663-668 (IF: 3.791, PCI:25)
Wagner S, Aust G, Schott M, Scherbaum WA, Feldkamp J. und Seissler J: Regulation of Sodium-iodide-symporter gene expression in human thyrocytes measured by real-time polymerase chain reaction. Exp Clin Endocr Diab 2002, 110:398-402 (IF: 1.685, PCI:4)
Willenberg HS, Mansman NG, Fritzen R, Schott M, Feldkamp J, Schulte HM, Scherbaum WA und Bornstein SR: The short synacthen test in the evaluation of adrenal masses in patients with malignancies. Endocr Res 2002, 28:793-7 (IF: 0.765, PCI:0)
Krüger T, Wohlrab U, Klucken M, Schott M und Seissler J: Autoantigen-specific protein of non-obese diabetic mice from cyclophosphamide-accelerated diabetes by vaccination with dendritic cells. Diabetologia 2003, 46:1357-1365 (IF: 6.551, PCI:13)
Schott M, Morgenthaler NG, Fritzen R, Feldkamp J, Scherbaum WA und Seissler J: Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves’ disease. Horm Metab Res 2004, 36(2):92-96 (IF: 2.686, PCI:39)
Rohr U B, Rehfeld N, Pflugfelder L, Geddert H, Steidl U, Fenk R, Gräf T, Schott M, Thiele K P, Gabbert H E, Germing U, Kronenwett R und Haas R: Expression of tyrosine kinase c-kit is an independent prognostic factor in patients with small cell lung cancer. Int J Cancer 2004, 111(2):259-63 (IF: 4.722, PCI:0)
Schott M, Minich WB, Willenberg H, Fritzen R, Papewalis C, Schinner S, Seissler J, Scherbaum WA und Morgenthaler NG: Relevance of TSH receptor stimulating and blocking autoantibodies measurement for the prediction of relapse in Graves’ disease. Horm Metab Res 2005, 37:741-4 (IF: 2.686, PCI:6)
Willenberg HS, Haase M, Papewalis C, Schott M, Scherbaum WA und Bornstein SR: Corticotropin-releasing hormone (CRH) receptor expression on normal and tumorous human adrenocortical cells. Neuroendocrinology 2005, 82:274-81 (IF: 3.074, PCI:10)
Papewalis C, Fassnacht M, Domberg J, Willenberg H, Schinner S, Bornstein SR, Scherbaum WA und Schott M: Dendritic cells as potential adjuvant for immunotherapy in adrenocortical carcinoma. Clin Endocrinol (Oxf) 2006, 65:215-22 (IF: 3.201, PCI:7)
Willenberg HS, Schott M, Saeger W, Tries A, Scherbaum WA und Bornstein SR: Expression of connexins in chromaffin cells of normal human adrenals, benign and malignant pheochromocytomas. Ann NY Acad Sci 2006, 1073:578-83 (IF: 2.670, PCI:3)
Schott M, Willenberg H, Jung M, Knoefel WT and Scherbaum WA: Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous sampling. Clin Endocrinol (Oxf) 2007, 66:405-9 (IF: 3.201, PCI:1)
Schott M, Eckstein A, Schinner S, Willenberg HS, Morgenthaler NG und Scherbaum WA: Improved prediction of relapse of Graves’ thyrotoxicosis by combined determination of TSH receptor and thyroperoxidase antibodies. Horm Metab Res 2007, 39:56-61 (IF: 2.686, PCI:12)
Haase M, Schott M, Bornstein SR, Malendowicz LK, Scherbaum WA und Willenberg HA: CITED2 is expressed in human adrenocortical cells and regulated by basic fibroblast growth factor. J Endocrinol 2007, 192:459-65 (IF: 2.860, PCI:10)
Schinner S, Willenberg HS, Krause D, Schott M, Ehrhart-Bornstein M, Bornstein SR und Scherbaum WA: Adipocyte-derived products induce the transcription of the StAR promoter and stimulate aldosterone and cortisol secretion from adrenocortical cells through the Wnt-signaling pathway. Int J Obesity 2007, 31:564-70 (IF: 4.343, PCI:18)
Wertenbruch T, Sagert C, Feldkamp J, Willenberg HS, Groeger C, Scherbaum WA und Schott M: Serum selenium levels in patients with remission and relapse of Graves’ disease. Med Chemistry 2007, 3: 281-4 (IF: 0,5, PCI:4)
Tran N, Koch A, Berkels R, Boehm O, Zacharowski PA, Baumgarten G, Knuefermann, Schott M, Kanczkowski W, Bornstein SR, Lightman SL und Zacharowski K: Toll-like receptor 9 expression in murine and human adrenal glands and possible implications during inflammation. J Clin Endocr Metab 2007, 92:2773-83 (IF: 6.202, PCI:11)
Korthals M, Safaian N, Maihöfer D, Lara M, Schott M, Papewalis C, Kronenwett R, Kobbe G, Haas R und Fenk R: Monocyte-derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis. J Transl Med 2007, 25:46 (IF: 3.407, PCI:11)
Cupisti K, Wolf A, Raffel A, Schott M, Miersch D, Yang Q, Eisenberger CF, Roher HD und Knoefel WT: Long term clinical follow up in medullary thyroid carcinoma: A single institution’s experience over 20 years. Ann Surg 2007, 246:815-821 (IF: 7.900, PCI:14)
Willenberg H, Bahlo M, Schott M, Wertenbruch T, Feldkamp J und Schrbaum WA: Helpful diagnostic markers of steroidogenesis for defining hyperandrogenemia in hirsute woman. Steroids 2008, 73:41-6 (IF: 2.905, PCI:2)
Schinner S, Ülgen F, Papewalis C, Schott M, Woelk A, Vidal-Puig A und Scherbaum WA: Regulation of insulin secretion, glucokinase gene transcription and ß-cell proliferation by adipocyte-derived wnt-signaling molecules. Diabetologia 2008, 51:147-54 (IF: 6.551, PCI:16)
Jacobs B, Papewalis C, Wuttke M, Ullrich E, Fenk R, Willenberg HS, Schinner S, Cohnen M, Seissler J, Zacharowski K, Scherbaum WA und Schott M: IFN skews Monocyte Differentiation into CD56+ expressing dendritic cells with potent functional activities in vitro and in vivo. J Immunol 2008, 180:1462-70 (IF: 5.646, PCI:15)
Jacobs B, Wuttke M, Papewalis C, Fenk R, Stüssgen C, Schinner S, Seissler J und Schott M: Characterization of monocyte-derived IFNalpha-generated dendritic cells. Horm Metab Res 2008, 40:117-21 (IF: 2.686, PCI:5)
Papewalis C, Wuttke M, Jacobs B, Willenberg HS, Fenke M, Seissler J, Scherbaum WA und Schott M: Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma. Horm Metab Res 2008, 40:108-16 (IF: 2.686, PCI:8)
Domberg J, Chao L, Papewalis C, Pfleger C, Xu K, Willenberg HS, Hermsen D, Scherbaum WA, Schloot NC und Schott M: Circulating chemokines in patients with autoimmune thyroid diseases. Horm Metab Res 2008, 40: 416-21 (IF: 2.686, PCI:9)
Papewalis C, Wuttke M, Seissler J, Meyer Y, Kessler C, Jacobs B, Ullrich E, Willenberg HS, Schinner S, Baehring T, Scherbaum WA und Schott M: Dendritic cell vaccination with xenogenic polypeptide hormone induces tumor rejection in neuroendocrine cancer. Clin Cancer Res 2008, 14: 4298-305 (IF: 6.747, PCI:4)
Sell MA, Schott M, Tharandt L, Cissewski C, Scherbaum WA und Willenberg HS: Functional central hypothyroidism in the elderly. Aging Clin Exp Res 2008, 20: 207-210 (IF: 1.255, PCI:2)
Liu C, Hermsen D, Domberg J, Graeber C, Hautzel H, Duan Y, Xu XF, Liu CP, Nao XD, Cupisti K, Scherbaum WA und Schott M: Comparison of M22-based ELISA and Human-TSH-Receptor-based Luminiscence Assay for the Measurement of Thyrotropin Receptor Autoantibodies in Patients with Thyroid Diseases. Horm Metab Res 2008, 40: 479-483 (IF: 2.686, PCI:8)
Lehwald N, Cupisti K, Willenberg HS, Schott M, Krausch M, Raffel A, Wolf A, Brinkmann K, Eisenberger CF, Knoefel WT. Standard-radical vs. function-preserving surgery of benign nodular goiter – a sonographic and biochemical 10 years-follow-up study. Langenbeck Arch Surg 2009, 394(2): 279-83 (IF: 1.572, PCI:0)
Wuttke M, Papewalis C, Meier Y, Kessler C, Jacobs B, Willenberg HS, Kouatchoua C, Seissler J, Baehring T, Scherbaum WA und Schott M: Amino acid-modified calcitonin immunization induces tumor epitope-specific immunity in a transgenic mouse model for medullary thyroid carcinoma. Endocrinology 2008, 149: 5627-5634 (IF: 4.752, PCI:1)
Brocker-Preuss M, Sheu SY, Worm K, Feldkamp J, Witte J, Scherbaum WA, Mann K, Schmid KW und Schott M: Expression and mutation analysis of the tyrosine kinase c-kit in poorly differentiated and anaplastic thyroid carcinoma and its possible clinical implication. Horm Metab Res 2008, 40: 685-691 (IF: 2.686, PCI:2)
Zhu J, Schott M, Liu R, Liu C, Shen B, Wang Q, Mao X, Yu K, Wu X, Schinner S, Papewalis C, Scherbaum WA und Liu C: Intensive glycemic control lowers plasma visfatin levels in patients with type 2 diabetes. Horm Metab Res 2008; 40: 801-805 (IF: 2.686, PCI:6)
Wu X, Schott M *, Liu C, Qian C, Mao X, Xu K, Jiang J, Xu Y, Shen M, Scherbaum WA und Liu C: Statins decrease the aberrant HLA-DR expression on thyrocytes from patients with Hashimoto’s thyroiditis. Horm Metab Res 2008 ,40(12):838-41 (* geteilte Erstautorenschaft mit Wu X) (IF: 2.686, PCI:0)
Willenberg HS, Ansurudeen I, Schebesta K, Haase M, Wess B, Schinner S, Schott M und Scherbaum WA: The endothelium secretes interleukin-6 (IL-6) and induces adrenal IL-6 generation that does not interfere with the effect of endothelial cells on aldosterone synthesis. Exp Clin Endocr Diab 2008, 116: S70-74 (IF: 1.685, PCI:2)
Schinner S, Kempf K, Overmann H, Willenberg HS, Schott M, Rose B, Scherbaum WA und Herder C: Association of Impaired glucose metabolism in morbid obesity with hypoadiponectinaemia. Exp Clin Endocr Diab 2008, 116: S64-69 (IF: 1.685, PCI:4)
Hermsen D, Liu C, Domberg J, Graeber C, Feldkamp J, Duan y, Xu K, Liu C, Mao X, Scherbaum WA und Schott M: Comparison of a solid phase human versus porcine thyrotropin receptor-based immunoassay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases. Exp Clin Endocr Diab 2008, 116: S59-63 (IF: 1.685, PCI:3)
Willenberg HS, Kolentini C, Quinkler M, Cupisti K, Krausch M, Schott M und Scherbaum WA: The sodium to urinary sodium to (potassium × potassium) to urinary potassium (SUSPPUP) ratio in primary aldosteronism. Eur J Clin Invest 2009, 39(1):43-50 (IF: 2.643, PCI:3)
Eckstein AK, Lösch C, Glowacka D, Schott M, Mann K, Esser J und Morgenthaler NG: Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetric Graves’ ophthalmopathy. Brit J Ophthalmol 2009, 93(8):1052-6 (IF: 2.917, PCI:2)
Hermsen D, Broecker-Preuss M, Casati M, Camara Mas J, Eckstein A, Gassner D, Golla R, van Helden J, Inomata K, Jarausch J, Kratzsch J, Mann K, Miyazaki N, Navarro Moreno MA, Murakami T, Roth HJ, Stock W, Yoshimura Noh J, Scherbaum WA und Schott M: Technical Evaluation of the First Automated Assay for the Detection of TSH Receptor Autoantibodies. Clin Chim Acta 2009, 401(1-2):84-9 (IF: 2.535, PCI:9)
Rohrbeck A, Neukirchen J, Rosskopf M, Garcia-Pardillos G, Geddert H, Schwalen A, Gabbert HE, von Haeseler A, Pitschke G, Schott M, Kronenwett R, Haas R, Rohr U-P: Gene expression profiling for molecular discrimination and characterization of laser captured primary lung cancers. J Transl Med 2008, 7;6:69 (IF: 3.407, PCI:4)
Lachenmayer A, Lichtenauer UD, Cox T, Schott M, Malendowicz LK, Goretzki PE, Cupisti C, Scherbaum WA, Bornstein SR und Willenberg HS: Nestin as a valuable marker in the classification of adrenocortical tumors. Horm Metab Res 2009, 41(5):397-401 (IF: 2.686, PCI:0)
Haase M, Ansurudeen I, Paramonova I, Schinner S, Schott M, Papewalis C, Krug A, Scherbaum WA und Willenberg HS: Evidence for the involvement of endothelial cell products in adrenal CITED2 expression. Cell Tissue Res 2009, 336(2):337-43 (IF: 2.308, PCI:1)
Gu J, Quan C, Tang W, Wu X, Liu C, Mao X, Xu K, Scherbaum WA, Schott M und Liu C: Polychlorinated Biphenyls affect thyroid function and induce autoimmunity in SD rats. Horm Metab Res 2009, 41(6):471-4 (geteilte Letztautorenschaft) (IF: 2.686, PCI:1)
Papewalis C, Wuttke M, Jacobs B, Willenberg HS, Schinner S, Scherbaum WA und Schott M: Role of the novel mTOR inhibitor RAD001 (Everolimus) in anaplastic thyroid carcinoma Horm Metab Res 2009,41(10):752-6 (IF: 2.686, PCI:9)
Menge T, Schloot NC, Schott M, Hemmer B, Wiendl H, Hartung H-P und Kieseier BC: Interferon beta treatment does not induce organ-specific autoantibodies in patients with multiple sclerosis. Neurology 2009, 73(11):900-2 (IF: 8.172, PCI:0)
Erlic Z, Rybicki L, Peczkowska M, Hohenberg W, Kann PH, Dralle H, Müssig K, Muresan M, Schäffler A, Reisch N, Schott M, Fassnacht M, Opocher G, Klose S, Fottner C, Forrer F, Plöckinger U, Peterssen S, Zabolotny D, Januszwicz A, Walz M, Eng C, und Neumann HPH for the European-American Pheochromocytoma Study Group: Clinical Predictors and Algorithm for the Genetic Diagnosis of Pheochromocytoma Patients. Clin Cancer Res. 2009, 15(20):6378-85 (IF: 6.747, PCI:11)
Erlic Z, Hoffmann MM, Peczkowska M, Harsch I, Schott M, Gabbert E, Valimäki M, Preuss SF, Hasse-Lazar K, Waligorski D, Franke G, Robledo M, Januszewicz A, Eng C and Neumann HPH: Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome. J Clin Endocr Metab. 2010, 95(1):308-13 (IF: 6.202, PCI:4)
Schott M, Hermsen D, Broecker-Preuss M, Casati M, Camara Mas J, Eckstein A, Gassner D, Golla R, Graeber C, van Helden J, Inomata K, Jarausch J, Kratzsch J, Miyazaki N, Navarro Moreno MA, Murakami T, Roth HJ, Stock W, Yoshimura Noh J, Scherbaum WA und Mann K: Clinical Evaluation of the First Automated TSH Receptor Autoantibody Assay: an International Multicenter Trial. Clin Endocrinol 2009, 71(4):566-73 (IF: 3.201, PCI:8)
Raffel A, Eisenberger CF, Cupisti K, Baldus SE, Topp SA, Schulte am Esch J, Peiper J, Schott M, Knoefel WT und Stoecklein NK: Increased EpCAM expression in malignant insulinoma: Potential clinical implication. Eur J Endocrinol. 2010, 162(2):391-8 (IF: 3.539, PCI:2)
Hermsen D, Eckstein A, Schinner S, Willenberg HS, Thiel A, Scherbaum WA, Schott M: Reproducibility of Elecsys(R) Anti-TSHR Test Results in a Lot-to-Lot Comparison. Horm Metab Res. 2010, 42(4):295-7 (IF: 2.686, PCI:2)
Willenberg HS, Späth M, Maser-Gluth C, Engers R, Anlauf M, Dekomien G, Schott M, Schinner S, Cupisti K, Scherbaum WA: Sporadic solitary aldosterone- and cortisol-cosecreting adenomas – endocrine function tests, histological and genetic
findings in a subtype of primary aldosteronism. Hypertens Res. 2010, 33(5):467-72 (IF: 2.426, PCI:1)
Ulgen F, Herder C, Kühn MC, Willenberg HS, Schott M, Scherbaum WA, Schinner S: Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients. Arch Physiol Biochem. 2010, 116(2):57-62 (IF:not listed, PCI:not listed)
Erlic Z, Ploeckinger U, Cascón A, Hoffmann MM, von Duecker L, Winter A, Kammel G, Bacher J, Sullivan M, Isermann B, Fischer L, Raffel A, Knoefel WT, Schott M, Baumann T, Schaefer O, Keck T, Baum RP, Milos I, Muresan M, Peczkowska M, Januszewicz A, Cupisti K, Tönjes A, Fasshauer M, Langrehr J, von Wussow P, Agaimy A, Schlimok G, Lamberts R, Wiech T, Schmid KW, Weber A, Nunez M, Robledo M, Eng C, Neumann HP: Systematic comparison of sporadic and syndromic pancreatic islet cell tumors. Endocr Relat Cancer. 2010, 17(4):875-83 (IF: 4.282, PCI:0)
Ulgen F, Kühn MC, Cupisti K, Herder C, Willenberg HS, Schott M, Scherbaum WA, Schinner S: The CB-1 Receptor Antagonist Rimonabant Modulates the Interaction Between Adipocytes and Pancreatic Beta-Cells in Vitro. Exp Clin Endocrinol Diabetes. 2010, 119(1):41-6 (IF: 1.685, PCI:not listed)
Balaş M, Zosin I, Maser-Gluth C, Hermsen D, Cupisti K, Schott M, Schinner S, Knoefel WT, Scherbaum WA, Willenberg HS: Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism. Hypertens Res. 2010 Aug;33(8):850-6 (IF: 2.426, PCI:0)
Paramonova I, Haase M, Mülders-Opgenoorth B, Ansurudeen-Rafi I, Bornstein SR, Papewalis C, Schinner S, Schott M, Scherbaum WA, Willenberg HS: The effects of the endothelium on adrenal steroidogenesis and growth are mainly mediated by proteins other than endothelin-1. Horm Metab Res. 2010, 42(12):840-5 (IF: 2.686, PCI:0)
Zöphel K, Roggenbuck D, Wunderlich G, Schott M: Continuously increasing sensitivity over three generations of TSH receptor autoantibody assays. Horm Metab Res. 2010, 42(12):900-2 (IF: 2.686, PCI:0)
Hautzel H, Pisar E, Yazdan-Doust N, Schott M, Beu M, Müller HW: Qualitative and quantitative impact of protective glucocorticoid therapy on the effective 131I half-life in radioiodine therapy for Graves disease. J Nucl Med. 2010, 51(12):1917-22 (IF: 6.424, PCI:0)
Lehwald N, Cupisti K, Willenberg HS, Schott M, Krausch M, Raffel A, Wolf A, Brinkmann K, Eisenberger CF und Knoefel WT. Standard-radical vs. function-preserving surgery of benign nodular goiter – a sonographic and biochemical 10 years-follow-up study. Langenbecks Arch Surg 2009, 394(2): 279-83 (Impact Factor: 1,5 / PCI: 0)
Papewalis C, Kouatchoua C, Ehlers M, Jacobs B, Porwol D, Schinner S, Willenberg HS, Anlauf M, Raffel A, Eisenhofer G, Neumann HP, Bornstein SR, Scherbaum WA, Schott M: Chromogranin A as potential target for immunotherapy of malignant pheochromocytoma. Mol Cell Endocrinol. 2010 Jun 22. [Epub ahead of print] (IF: 3.503, PCI:not listed)
Papewalis C, Jacobs B, Baran AM, Ehlers M, Stoecklein NH, Willenberg HS, Schinner S, Anlauf M, Raffel A, Cupisti K, Fenk R, Scherbaum WA, Schott M: Increased Numbers of Tumor-lysing Monocytes in Cancer Patients. Mol Cell Endocrinol. 2011 Jan 31. [Epub ahead of print] (IF: 3.503, PCI:not listed)
Liu C, Scherbaum WA, Schott M und Schinner S: Subclinical hypothyroidism and the prevalence of metabolic syndrome. Horm Metab Res 2011 (akzeptiert; IF: 2.686, PCI:0)